ClinicalTrials.govpublic full text
Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions
acute coronary syndrome, angioplasty, transluminal, percutaneous coronary, hydroxymethylglutaryl-coa reductase inhibitors, blood platelets, platelet activation, platelet leukocyte aggregates, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 897826
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.